Elevance Health (ELV) Share-based Compensation (2010 - 2026)

Elevance Health (ELV) has 17 years of Share-based Compensation data on file, last reported at $1.0 million in Q2 2026.

• On a quarterly basis, Share-based Compensation fell 97.44% year-over-year to $1.0 million in Q2 2026; TTM through Jun 2026 was -$95.0 million, a 137.55% decrease from a year earlier, with the FY2025 full-year figure at $32.0 million, down 83.25% from the prior year.
• Share-based Compensation for Q2 2026 stood at $1.0 million, down from $34.0 million in the prior quarter.
• Over the last five years, Share-based Compensation for ELV reached as high as $190.0 million in Q4 2023 and fell as low as -$214.0 million in Q4 2025.
• Historically, Share-based Compensation has averaged $45.1 million across 5 years, with a median of $40.0 million in 2023.
• Across the five-year window, Share-based Compensation plunged 1433.33% in 2023 and soared 400.0% in 2024, its largest moves.
• Year by year, Share-based Compensation stood at $173.0 million in 2022, then rose by 9.83% to $190.0 million in 2023, then slumped by 115.26% to -$29.0 million in 2024, then sank by 637.93% to -$214.0 million in 2025, then soared by 100.47% to $1.0 million in 2026.
• Per Business Quant data, the three most recent Share-based Compensation figures were $1.0 million in Q2 2026, $34.0 million in Q1 2026, and -$214.0 million in Q4 2025.